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Background
The conserved membrane-proximal external region
(MPER) of HIV-1 envelope is a target for the rare broadly
neutralizing 2F5, Z13 and 4E10 monoclonal antibodies
(mAbs). However, MPER antibodies are rarely found in
HIV-1 infected subjects nor arise following envelope
immunization. A potential strategy to elicit such antibod-
ies more frequently is to design an envelope protein with
increased exposure of the 2F5 and 4E10 mAb epitopes.
Methods
Using pseudotyped virus neutralization assays and surface
plasmon resonance (SPR) assays (with both peptides and
peptide-liposome conjugates), we characterize an HIV-1
envelope mutant pseudovirus that is ~300 fold more sen-
sitive to 2F5 and 4E10 neutralization than wildtype.
Results
The mutation responsible is a single leucine to serine sub-
stitution at position 669 in the gp41 Env MPER. A non-
neutralizing MPER mAb, 13H11, which binds peptides
with gp41 669 leucine but not 669 serine, did not interact
with L669 peptide-lipid conjugates, consistent with previ-
ously observed masking of L669 when peptide is lipid-
associated. In contrast, the 2F5 mAb, which recognizes an
epitope C-terminal to the 13H11 mAb, bound more sta-
bly, with a slower off-rate, to MPER L669S mutant pep-
tide-lipid conjugates than to wild-type peptide-lipid
conjugates.
Conclusion
These data suggest that the L669S mutation in the gp41
MPER creates a virus that is more susceptible to neutraliz-
ing MPER antibodies because of enhanced exposure of the
neutralizing epitope. Inactivated pseudotyped virus or
subunit immunogens with the L669S gp41 MPER muta-
tion may be candidates for induction of MPER neutraliz-
ing antibodies.
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